The Top Vaccine Stocks Worth Watching Immediately


Months into the pandemic, more companies are entering the final stages of vaccine testing.

For example, Novavax (NVAX) said it would start its Phase 3 trial among 30,000 people in the UK.  In addition, a trial of 30,000 could begin in the U.S. if regulators are pleased with the safest of a Phase 2 trial under way at the moment, according to Barron’s.

The latest study in the UK will track whether adults receiving a two-dose vaccine see a lower rate of symptomatic COVID, as compared to those...

Register Now

The Daily Chart Newsletter is available only to members of this site. Register now for FREE. No cost, no obligation, join today.

Already a member? Login below, or click here to register now for free.